In the past year, we generated and analyzed a mouse model carrying a mutation that blocks the slicing between BRCA1 exons 10 and 11. Alternative splicing in the BRCA1 locus generates multiple protein products including BRCA1-Delta11, which is identical to the BRCA1 full-length isoform (BRCA1-FL) except for the absence of exon 11. To understand the physiologic functions of BRCA1-Delta11, we used a knock-in approach that blocks alternative splicing between exons 10 and 12 to prevent the formation of this form of BRCA1. We showed that homozygous mutant mice (Brca1(FL/FL)) were born at a Mendelian ratio without obvious developmental defects. However, the majority of Brca1(FL/FL) female mice showed mammary gland abnormalities and uterine hyperplasia after one year of age with spontaneous tumor formation. Cultured Brca1(FL/FL) cells exhibited abnormal centrosome amplification and reduction of G(1) population that was accompanied by accumulation of cyclin E and cyclin A. Accumulation of cyclin E was also found in epithelial layers of dilated ducts and hyperproliferative lobular regions in the mammary glands of Brca1(FL/FL) mice. These observations provide evidence that BRCA1 splicing variants are involved in BRCA1 functions in modulating G(1)/S transition, centrosome duplication, and repressing tumor formation. Thus, together with mutant mice generated earlier, we have generated and reported a total of five mutant models for BRCA1, including two null mutations, one conditional mutation, two isoform mutations and one point mutation. Our studies using these models demonstrate that BRCA1 plays essential functions in many biological processes, including transcription regulation, cell cycle progression, apoptosis, DNA damage repair, centrosome duplication and animal aging.

Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
2008
Total Cost
$480,114
Indirect Cost
City
State
Country
United States
Zip Code
Lahusen, Tyler J; Deng, Chu-Xia (2015) SRT1720 induces lysosomal-dependent cell death of breast cancer cells. Mol Cancer Ther 14:183-92
Cao, Liu; Xu, Xiaoling; Cao, Longyue L et al. (2007) Absence of full-length Brca1 sensitizes mice to oxidative stress and carcinogen-induced tumorigenesis in the esophagus and forestomach. Carcinogenesis 28:1401-7
Tominaga, Y; Wang, A; Wang, R-H et al. (2007) Genistein inhibits Brca1 mutant tumor growth through activation of DNA damage checkpoints, cell cycle arrest, and mitotic catastrophe. Cell Death Differ 14:472-9
Kim, Sang Soo; Cao, Liu; Lim, Sung-Chul et al. (2006) Hyperplasia and spontaneous tumor development in the gynecologic system in mice lacking the BRCA1-Delta11 isoform. Mol Cell Biol 26:6983-92
Xu, Xiaoling; Kobayashi, Shogo; Qiao, Wenhui et al. (2006) Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice. J Clin Invest 116:1843-52
Wang, X; Zhou, Y-X; Qiao, W et al. (2006) Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation. Oncogene 25:7148-58
Deng, Chu-Xia (2006) BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res 34:1416-26
Park, Changwon; Lavine, Kory; Mishina, Yuji et al. (2006) Bone morphogenetic protein receptor 1A signaling is dispensable for hematopoietic development but essential for vessel and atrioventricular endocardial cushion formation. Development 133:3473-84
De Soto, Joseph A; Deng, Chu-Xia (2006) PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers? Int J Med Sci 3:117-23
Oppermann, Mona; Mizel, Diane; Huang, George et al. (2006) Macula densa control of renin secretion and preglomerular resistance in mice with selective deletion of the B isoform of the Na,K,2Cl co-transporter. J Am Soc Nephrol 17:2143-52

Showing the most recent 10 out of 96 publications